Therapeutic Group: Oncology Presentation Soracent 200: Each tablet contains Sorafenib Tosylate INN equivalent to Sorafenib 200 mg Description Sorafenib is a kinase inhibitor that decreases tumor cell proliferation in vitro. Sorafenib was shown to inhibit multiple intracellular (CRAF, BRAF, and mutant BRAF) and cell surface kinases (KIT, FLT-3, RET, VEGFR-1, VEGFR-2, VEGFR-3, and PDGFR-ß). Several […]